June 01, 2020
Boston’s biotech industry raised more than $1.5 billion in venture capital funding in May, BostInno reported. Among the handful of startups to benefit from funding include Amwell, a Boston-based telemedicine company, that raised $194 million in Series C funding as some doctors treat patients by video messaging; Atea Pharmaceuticals, a Boston-based developer of therapies for […]
